Open | - |
Close | - |
Volume / Avg. | 0 / 453.729K |
Day Range | - - - |
52 Wk Range | 15.570 - 29.510 |
Market Cap | $654.979M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 28 |
Short Interest | % |
Days to Cover | 4.84 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of SI-BONE (NASDAQ: SIBN) through any online brokerage.
Other companies in SI-BONE’s space includes: Axogen (NASDAQ:AXGN), NeuroPace (NASDAQ:NPCE), Varex Imaging (NASDAQ:VREX), Alphatec Holdings (NASDAQ:ATEC) and NovoCure (NASDAQ:NVCR).
The latest price target for SI-BONE (NASDAQ: SIBN) was reported by Morgan Stanley on Tuesday, February 27, 2024. The analyst firm set a price target for 26.00 expecting SIBN to rise to within 12 months (a possible 63.01% upside). 21 analyst firms have reported ratings in the last year.
The stock price for SI-BONE (NASDAQ: SIBN) is $15.95 last updated March 18, 2024 at 4:20 PM EDT.
There are no upcoming dividends for SI-BONE.
SI-BONE’s Q1 earnings are confirmed for Monday, April 29, 2024.
There is no upcoming split for SI-BONE.
SI-BONE is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.